Greenwich LifeSciences, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Greenwich LifeSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Greenwich LifeSciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.66M, a 52.3% decline year-over-year.
  • Greenwich LifeSciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.5M, a 13.7% decline year-over-year.
  • Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2023 was -$9.33M, a 16% decline from 2022.
  • Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2022 was -$8.04M, a 74.9% decline from 2021.
  • Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2021 was -$4.6M, a 147% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.33M -$1.29M -16% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 -$8.04M -$3.44M -74.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 -$4.6M -$2.73M -147% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$1.86M +$1.56M +45.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$3.43M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.